InsidersTradesSigma
申报总数
公司
▲ 买入（4 笔）
▼ 卖出（2 笔）
内部人交易记录
首席执行官已披露买入
4
已披露卖出
2
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Browse the complete record of transactions filed by Hasnain Faheem, Président et CEO. Officer active across 3 companies, notably Mirati Therapeutics, Inc.. In total, 15 disclosures have been logged. Breakdown: 4 buys · 2 sells. Total volume traded: €1.8m. History available since 14 January 2022. The latest transaction was filed on 2 January 2026 (Attribution). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Hasnain Faheem
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报15 总计
280,000 股0Common StockSEC:0001352620-26-000002:0
10,000 股@ US$3.1216.9% 占其流量Common StockSEC:0001193125-25-314154:0
437,500 股0Common StockSEC:0001352620-25-000004:0
22,682 股@ US$6.32100.0% 占其流量Common StockSEC:0000950170-25-043903:0
372,000 股@ US$0.67289.5% 占其流量Common StockSEC:0001728117-24-000076:0
标准退出：2024年9月19日 (T+90)
23,172 股@ US$1.15541.0% 占其流量Common StockSEC:0001728117-24-000037:0
8,717 股Common StockSEC:0001140361-24-003533:0
9,702 股@ US$58.7565.3% 占其流量Common StockSEC:0001628280-24-000294:0
10,791 股@ US$27.8034.7% 占其流量Common StockSEC:0001209191-23-045653:0
标准退出：2023年11月9日 (T+90)
540,176 股@ US$1.8236.1% 占其流量Common StockSEC:0001728117-23-000099:0
168,683 股@ US$1.03446.6% 占其流量Common StockSEC:0001728117-23-000018:0
标准退出：2023年6月18日 (T+90)
6,333 股0Common StockSEC:0001214659-23-001046:0
138,696 股@ US$7.2140.5% 占其流量Common StockSEC:0001728117-22-000059:0
标准退出：2022年10月13日 (T+90)
19,035 股@ US$8.9156.2% 占其流量Common StockSEC:0001728117-22-000031:0
3,619 股0Common StockSEC:0001214659-22-000854:0
15 条申报中的 15 条
About Hasnain Faheem
Hasnain Faheem is Président et CEO. He has 15 filings in total. Among the 15 sampled recent filings between 2022-01-18 and 2026-01-05, buys amount to EUR 1667774 and sells to EUR 178570, with transactions mainly of the Attribution type. The filings covered relate to Gossamer Bio, Inc., Mirati Therapeutics, Inc. and Kura Oncology, Inc.
